SCHEMBL4769812

SCHEMBL4769812

O=c1c([N+](=O)[O-])c(C=Cc2cnn(-c3ccccc3)c2)n(C2CCC2)c(=O)n1Cc1ccncc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.37
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
CACNA1B Q00975 1/20 0.35
APBA1 Q02410 1/20 0.35
CYP3A4 P08684 7/20 0.35
CYP2D6 P10635 7/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ACKR3 P25106 1/20 0.33
HSPD1 P10809 1/20 0.32
HSPE1 P61604 1/20 0.32
TSHR P16473 1/20 0.32
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4769797 1.00 PDE4A (0.37) PDE4AMEN1KMT2AKDM4EALDH1A1
SCHEMBL4769434 0.88 PARG (0.36) PDE4AMEN1KMT2AALDH1A1MAPT
SCHEMBL4769440 0.88 PARG (0.36) PDE4AMEN1KMT2AALDH1A1MAPT
SCHEMBL4762557 0.87 KMT2A (0.40) PDE4AMEN1KMT2AKDM4EALDH1A1
SCHEMBL4762556 0.87 KMT2A (0.40) PDE4AMEN1KMT2AKDM4EALDH1A1
SCHEMBL4767470 0.86 NPC1 (0.41) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL4767463 0.86 NPC1 (0.41) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL4866193 0.84 PDE4A (0.39) PDE4AMEN1KMT2ACYP3A4CYP2D6
SCHEMBL4763924 0.84 NPSR1 (0.33) PDE4AALDH1A1MAPTCYP3A4CYP2D6
SCHEMBL4763921 0.84 NPSR1 (0.33) PDE4AALDH1A1MAPTCYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed